Heart of the Matter: SVT and the RP Interval

October 7, 2025

A 66-year-old female with a past medical history of acute myeloid leukemia on chemotherapy complicated by tumor lysis syndrome and myelofibrosis presents for a concern of hypotension and tachycardia which was noted on presentation to the outpatient infusion clinic. The patient states she has been feeling well and her last chemo was a month ago. The patient denies any physical manifestations including shortness of breath, chest pain, nausea, vomiting, or other symptoms at present. She does have a history of supraventricular tachycardia (SVT).

Erica Dolph MD and Ari Edelheit MD

Pharm & Cheese: TXA in Pediatrics

September 22, 2025

Clinical Question: What is the dose of Nebulized Tranexamic Acid for Pediatric Post-tonsillectomy Hemorrhage? How do we administer it? 

Mariam Isa, PharmD and Joanne Routsolias, PharmD

Pharm & Cheese: Asymptomatic Hyperglycemia

September 22, 2025

Imagine. You're on a busy red team shift. A clinic calls to send a patient with asymptomatic hyperglycemia to the ED. You roll your eyes, transfer it to the attending. The patient of course lands in the resus bay and you go to evaluate them. Their sugar is 450 mg/dL, they have no symptoms and their vitals are normal. You mindlessly order a VBG, basic labs and a liter of fluid and move on with your day. However, is this all necessary? What should our end goal be? What should I choose as my intervention if necessary? Do I even need labs?

Kathryn McGregor MD, Joanne Routsolias PharmD, and Eric Leser MD

the County Consult